Literature DB >> 7584955

Microsatellite instability in primary neoplasms from HIV + patients.

G C Bedi1, W H Westra, H Farzadegan, P M Pitha, D Sidransky.   

Abstract

AIDS is associated with a high risk of certain malignancies, notably Kaposi's sarcoma (KS) and B-cell non-Hodgkin's lymphoma (NHL). The pathogenesis of these malignancies is not fully understood. One mechanism of malignant transformation recently described in colon tumorigenesis results from defects in DNA mismatch repair, manifest as widespread microsatellite instability. We demonstrate a high rate of microsatellite instability in KS and aggressive lymphomas obtained from HIV-infected patients, whereas there is no evidence of instability in similar lesions from HIV-negative patients. Further elucidation of the underlying mechanisms responsible for HIV-associated instability in primary tumours may provide insight into the pathogenesis of these AIDS-related neoplasms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584955     DOI: 10.1038/nm0195-65

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  14 in total

1.  Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Authors:  M Sol Mateo; M Mollejo; R Villuendas; P Algara; M Sánchez-Beato; B Martinez-Delgado; P Martínez; M A Piris
Journal:  Mol Pathol       Date:  1998-10

Review 2.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

Review 3.  Genetic abnormalities in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Authors:  M Merup
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

Review 4.  The application of microsatellites in molecular pathology.

Authors:  R Naidoo; R Chetty
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

5.  Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.

Authors:  Nancy F Crum-Cianflone; Xun Wang; Anuradha Ganesan; Jason Okulicz; Amy Weintrob; Tahaniyat Lalani; Brian Agan
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

Review 6.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

7.  Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients.

Authors:  Carlie Sigel; Marcela S Cavalcanti; Tanisha Daniel; Efsevia Vakiani; Jinru Shia; Keith Sigel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-13       Impact factor: 4.254

8.  Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.

Authors:  H Peng; G Chen; M Du; N Singh; P G Isaacson; L Pan
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

9.  Analysis of microsatellite instability in chronic lymphoproliferative disorders.

Authors:  G Volpe; B Gamberi; C Pastore; A Roetto; M Pautasso; G Parvis; C Camaschella; U Mazza; G Saglio; G Gaidano
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

10.  The mutator pathway is a feature of immunodeficiency-related lymphomas.

Authors:  Alex Duval; Martine Raphael; Caroline Brennetot; Helene Poirel; Olivier Buhard; Alban Aubry; Antoine Martin; Amor Krimi; Veronique Leblond; Jean Gabarre; Frederic Davi; Frederic Charlotte; Francoise Berger; Gianluca Gaidano; Daniela Capello; Danielle Canioni; Dominique Bordessoule; Jean Feuillard; Philippe Gaulard; Marie Helene Delfau; Sophie Ferlicot; Virginie Eclache; Sophie Prevot; Catherine Guettier; Pascale Cornillet Lefevre; Francoise Adotti; Richard Hamelin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.